A Look at Recent Proposals to Control Drug Spending by Medicare and its Beneficiaries November 26, 2019 Issue Brief In response to higher drug spending growth and heightened attention to drug prices, policymakers have proposed a variety of policy initiatives to lower the cost of prescription drugs in Medicare. This brief examines in detail the range of proposals offered by the Trump Administration and members of Congress for lowering the cost of prescription drugs, their known effects on the federal budget, and their potential implications for beneficiaries and other stakeholders.
Analysis Finds that Medications for Hepatitis C and HIV/AIDS Are the Costliest Group of Outpatient Prescription Drugs for Medicaid, While Diabetes Drugs Have Posted the Sharpest Rise in Costs February 15, 2019 News Release Antiviral medications, including those that treat hepatitis C and HIV/AIDS, cost the Medicaid program more money (before rebates) than any other group of outpatient prescription drugs for each year from 2014 to 2017, according to a new KFF analysis. The analysis of utilization and spending trends finds that antivirals accounted…
Data Note: Impact of New Title X Regulations on Network Participation September 20, 2019 Issue Brief This data note provides estimates of the status of the Title X network following the implementation of the new regulations.
What Steps Are Washington Policymakers Pursuing to Control Medicare Prescription Drug Spending? August 1, 2019 News Release As policymakers in Washington discuss ways to curb the rising cost of prescription drugs, KFF has released a summary and analysis of proposals and recently finalized initiatives that affect Medicare prescription drug spending. Medicare, the federal health program that covers more than 60 million seniors and younger people with disabilities,…
Health Policy Resources for Covering the Democratic Presidential Primary Debates December 16, 2019 News Release A collection of key health policy resources for journalists covering the Democratic presidential primary debates.
How Will The Medicare Part D Benefit Change Under Current Law and Leading Proposals? October 11, 2019 Issue Brief This brief describes how the Medicare Part D benefit will change in 2020 under current law and proposed changes that would affect what beneficiaries, plans, manufacturers, and Medicare pay for drug costs under Part D in the future.
Contraceptive Implants October 1, 2019 Fact Sheet The contraceptive implant is the most effective method of birth control available, and while it’s use is still low compared to other methods, its provision and use are increasing.
Medicaid’s Prescription Drug Benefit: Key Facts May 1, 2019 Fact Sheet Medicaid provides health coverage for millions of Americans, including prescription drug coverage for many people with substantial health needs. This fact sheet provides an overview of Medicaid’s prescription drug benefit and recent trends in spending and utilization
Kaiser Health News (KHN) announces a new partnership with An Arm and A Leg podcast May 23, 2019 News Release KFF and Public Road Productions announce that Season 2 of An Arm and A Leg podcast will be co-produced in partnership with Kaiser Health News (KHN), KFF’s editorially independent national health and health policy newsroom.
Annual Out-of-Pocket Costs for Insulin Nearly Doubled Over a Decade for Medicare Part D Enrollees April 4, 2019 Slide Out-of-pocket insulin costs for Medicare Part D enrollees with incomes too high to qualify for low-income subsidies increased 81% from 2007 to 2016. Learn more in the latest Chart of the Week.